{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:04:35Z","timestamp":1784135075941,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018935","name":"Universit\u00e4tsklinikum Erlangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018935","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The effectiveness of antidepressants (ADs) in the treatment of depression is continuously discussed regarding its clinical relevance. The objective of this study was to explore thresholds of members of the public for effectiveness of ADs relative to the frequency of adverse drug reactions (ADRs) deemed acceptable. We conducted a cross-sectional online survey in Germany that included individuals with and without experiences of depression and ADs. Participants were presented a case scenario describing a moderate depressive episode, operationalized with the Montgomery \u00c5sberg Depression Rating Scale (MADRS). Participants were asked to rate the effectiveness of different treatment options, estimate the frequency of 15 ADRs, and indicate the minimal level of treatment effectiveness they would require to accept certain ADRs. The survey was completed by 208 participants (144 female, 64 male), 44 were taking ADs. The effectiveness of ADs was significantly overestimated (\n                    <jats:italic>t<\/jats:italic>\n                    (204)\u2009=\u20098.96,\n                    <jats:italic>p<\/jats:italic>\n                    &lt; 0.001,\n                    <jats:italic>d<\/jats:italic>\n                    \u2009=\u20090.63). For 13 ADRs, participants selected package-insert frequency categories that were significantly lower than the corresponding reference categories. For example, to accept the potential ADR of seizures, participants required a symptom improvement of\n                    <jats:italic>M<\/jats:italic>\n                    \u2009=\u200923.51 (\n                    <jats:italic>SD<\/jats:italic>\n                    \u2009=\u20098.82) points on the MADRS. We propose that patient-physician communication about risks and benefits of AD treatment should explicitly address individual expectations.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-62116-y","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:50:26Z","timestamp":1784130626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Public thresholds for antidepressant effectiveness and adverse drug reaction rates: a cross-sectional study"],"prefix":"10.1038","volume":"16","author":[{"given":"Katharina","family":"Apel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Scheel-Barteit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Berking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"K\u00fchlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0838-7989","authenticated-orcid":false,"given":"Maria","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"62116_CR1","doi-asserted-by":"publisher","unstructured":"Wittchen, H. U. et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology 21, 655\u2013679. https:\/\/doi.org\/10.1016\/j.euroneuro.2011.07.018 (2011).","DOI":"10.1016\/j.euroneuro.2011.07.018"},{"key":"62116_CR2","unstructured":"Bretschneider, J., Kuhnert, R. & Hapke, U. Vol. 2 (Robert Koch-Institut, Epidemiologie und Gesundheitsberichterstattung, (2017)."},{"key":"62116_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00103-013-1688-3","volume":"56","author":"MA Busch","year":"2013","unstructured":"Busch, M. A., Maske, U. E., Ryl, L., Schlack, R. & Hapke, U. Pr\u00e4valenz von depressiver Symptomatik und diagnostizierter Depression bei Erwachsenen in Deutschland. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 56, 733\u2013739. https:\/\/doi.org\/10.1007\/s00103-013-1688-3 (2013).","journal-title":"Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"},{"key":"62116_CR4","unstructured":"B\u00c4K) B., (KBV), K. B. & (AWMF), A. d. W. M. F. Nationale Versorgungsleitlinie Unipolare Depression - Langfassung, Version 3.2. (2022)."},{"key":"62116_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0031-1276865","volume":"38","author":"T Baghai","year":"2011","unstructured":"Baghai, T. et al. Antidepressiva bei leichten depressiven St\u00f6rungen. Psychiatr. Prax. 38, 270\u2013273. https:\/\/doi.org\/10.1055\/s-0031-1276865 (2011).","journal-title":"Psychiatr. Prax."},{"key":"62116_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/wps.20249","volume":"14","author":"P Cuijpers","year":"2015","unstructured":"Cuijpers, P. & Cristea, I. A. What if a placebo effect explained all the activity of depression treatments? World Psychiatry. 14, 310\u2013311. https:\/\/doi.org\/10.1002\/wps.20249 (2015).","journal-title":"World Psychiatry"},{"key":"62116_CR7","doi-asserted-by":"crossref","unstructured":"Hengartner, M. P. & Pl\u00f6derl, M. Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter! Frontiers Psychiatry. 9, 1-5 (2018).","DOI":"10.3389\/fpsyt.2018.00517"},{"key":"62116_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/bmjebm-2019-111238","volume":"25","author":"JC Jakobsen","year":"2020","unstructured":"Jakobsen, J. C., Gluud, C. & Kirsch, I. Should antidepressants be used for major depressive disorder? BMJ Evidence-Based Med. 25, 130. https:\/\/doi.org\/10.1136\/bmjebm-2019-111238 (2020).","journal-title":"BMJ Evidence-Based Med."},{"key":"62116_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cct.2006.10.012","volume":"28","author":"I Kirsch","year":"2007","unstructured":"Kirsch, I. & Moncrieff, J. Clinical trials and the response rate illusion. Contemp. Clin. Trials. 28, 348\u2013351. https:\/\/doi.org\/10.1016\/j.cct.2006.10.012 (2007). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"Contemp. Clin. Trials"},{"key":"62116_CR10","doi-asserted-by":"crossref","unstructured":"Lohse, M. J. & M\u00fcller-Oerlinghausen, B. in Arzneiverordnungs-Report 2019 (eds Ulrich Schwabe, Dieter Paffrath, Wolf-Dieter Ludwig, & J\u00fcrgen Klauber) 927\u2013959Springer Berlin Heidelberg, (2019).","DOI":"10.1007\/978-3-662-59046-1_41"},{"key":"62116_CR11","doi-asserted-by":"publisher","first-page":"e024886","DOI":"10.1136\/bmjopen-2018-024886","volume":"9","author":"K Munkholm","year":"2019","unstructured":"Munkholm, K., Paludan-M\u00fcller, A. S. & Boesen, K. Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis. BMJ Open. 9, e024886. https:\/\/doi.org\/10.1136\/bmjopen-2018-024886 (2019).","journal-title":"BMJ Open."},{"key":"62116_CR12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12888-019-2230-4","volume":"19","author":"M Pl\u00f6derl","year":"2019","unstructured":"Pl\u00f6derl, M. & Hengartner, M. P. Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelines. BMC Psychiatry. 19, 265. https:\/\/doi.org\/10.1186\/s12888-019-2230-4 (2019).","journal-title":"BMC Psychiatry"},{"key":"62116_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/bmjebm-2020-111600","volume":"27","author":"MP Hengartner","year":"2022","unstructured":"Hengartner, M. P. & Pl\u00f6derl, M. Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression. BMJ Evidence-Based Med. 27, 69. https:\/\/doi.org\/10.1136\/bmjebm-2020-111600 (2022).","journal-title":"BMJ Evidence-Based Med."},{"key":"62116_CR14","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","volume":"5","author":"I Kirsch","year":"2008","unstructured":"Kirsch, I. et al. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration. PLoS Med. 5, e45. https:\/\/doi.org\/10.1371\/journal.pmed.0050045 (2008).","journal-title":"PLoS Med."},{"key":"62116_CR15","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","volume":"28","author":"J Moncrieff","year":"2023","unstructured":"Moncrieff, J. et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol. Psychiatry. 28, 3243\u20133256. https:\/\/doi.org\/10.1038\/s41380-022-01661-0 (2023).","journal-title":"Mol. Psychiatry"},{"key":"62116_CR16","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1038\/tp.2012.57","volume":"2","author":"DE Adkins","year":"2012","unstructured":"Adkins, D. E. et al. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D. Transl Psychiatry. 2, e129. https:\/\/doi.org\/10.1038\/tp.2012.57 (2012).","journal-title":"Transl Psychiatry"},{"key":"62116_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.euroneuro.2013.05.001","volume":"23","author":"PM Bet","year":"2013","unstructured":"Bet, P. M., Hugtenburg, J. G., Penninx, B. W. & Hoogendijk, W. J. Side effects of antidepressants during long-term use in a naturalistic setting. Eur. Neuropsychopharmacol. 23, 1443\u20131451. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.05.001 (2013).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"62116_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12888-016-1173-2","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen, J. C. et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 17, 58. https:\/\/doi.org\/10.1186\/s12888-016-1173-2 (2017).","journal-title":"BMC Psychiatry"},{"key":"62116_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamainternmed.2016.8254","volume":"177","author":"TC Hoffmann","year":"2017","unstructured":"Hoffmann, T. C. & Del Mar, C. Clinicians\u2019 Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review. JAMA Intern. Med. 177, 407\u2013419. https:\/\/doi.org\/10.1001\/jamainternmed.2016.8254 (2017).","journal-title":"JAMA Intern. Med."},{"key":"62116_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamainternmed.2014.6016","volume":"175","author":"TC Hoffmann","year":"2015","unstructured":"Hoffmann, T. C. & Del Mar, C. Patients\u2019 Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review. JAMA Intern. Med. 175, 274\u2013286. https:\/\/doi.org\/10.1001\/jamainternmed.2014.6016 (2015).","journal-title":"JAMA Intern. Med."},{"key":"62116_CR21","doi-asserted-by":"publisher","first-page":"e0272985","DOI":"10.1371\/journal.pone.0272985","volume":"17","author":"P van der Keylen","year":"2022","unstructured":"van der Keylen, P., Zeschick, N., Schlenz, A. R. & K\u00fchlein, T. Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication\u2013Survey among physicians and lay persons in Germany. Plos one. 17, e0272985 (2022).","journal-title":"Plos one"},{"key":"62116_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.biopsych.2005.09.014","volume":"59","author":"HC Kraemer","year":"2006","unstructured":"Kraemer, H. C. & Kupfer, D. J. Size of Treatment Effects and Their Importance to Clinical Research and Practice. Biol. Psychiatry. 59, 990\u2013996. https:\/\/doi.org\/10.1016\/j.biopsych.2005.09.014 (2006). https:\/\/doi.org\/https:\/\/doi.","journal-title":"Biol. Psychiatry"},{"key":"62116_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1046\/j.1525-1497.2002.11111.x","volume":"17","author":"M Man-Son-Hing","year":"2002","unstructured":"Man-Son-Hing, M. et al. Determination of the clinical importance of study results. J. Gen. Intern. Med. 17, 469\u2013476. https:\/\/doi.org\/10.1046\/j.1525-1497.2002.11111.x (2002).","journal-title":"J. Gen. Intern. Med."},{"key":"62116_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke, R., Singer, J. & Guyatt, G. H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin. Trials. 10, 407\u2013415. https:\/\/doi.org\/10.1016\/0197-2456(89)90005-6 (1989).","journal-title":"Control Clin. Trials"},{"key":"62116_CR25","doi-asserted-by":"publisher","first-page":"e0229381","DOI":"10.1371\/journal.pone.0229381","volume":"15","author":"MP Hengartner","year":"2020","unstructured":"Hengartner, M. P., Jakobsen, J. C., S\u00f8rensen, A. & Pl\u00f6derl, M. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. PLOS ONE. 15, e0229381. https:\/\/doi.org\/10.1371\/journal.pone.0229381 (2020).","journal-title":"PLOS ONE"},{"key":"62116_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.arthro.2022.11.001","volume":"39","author":"MJ Rossi","year":"2023","unstructured":"Rossi, M. J., Brand, J. C. & Lubowitz, J. H. Minimally Clinically Important Difference (MCID) Is a Low Bar. Arthroscopy: J. Arthroscopic Relat. Surg. 39, 139\u2013141. https:\/\/doi.org\/10.1016\/j.arthro.2022.11.001 (2023).","journal-title":"Arthroscopy: J. Arthroscopic Relat. Surg."},{"key":"62116_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4065\/77.4.371","volume":"77","author":"GH Guyatt","year":"2002","unstructured":"Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W. & Norman, G. R. Methods to Explain the Clinical Significance of Health Status Measures. Mayo Clin. Proc. 77, 371\u2013383. https:\/\/doi.org\/10.4065\/77.4.371 (2002).","journal-title":"Mayo Clin. Proc."},{"key":"62116_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A. et al. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42, 377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010 (2009).","journal-title":"J. Biomed. Inform."},{"key":"62116_CR29","doi-asserted-by":"crossref","unstructured":"Eysenbach, G. Vol. 6 e34Gunther Eysenbach Centre for Global eHealth Innovation, Toronto, Canada, (2004).","DOI":"10.2196\/jmir.6.3.e35"},{"key":"62116_CR30","doi-asserted-by":"crossref","unstructured":"Nielsen, J. Usability engineering (Academic, 1993).","DOI":"10.1016\/B978-0-08-052029-2.50007-3"},{"key":"62116_CR31","unstructured":"Organization, W. H. (World Health Organization, (1992)."},{"key":"62116_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10459-010-9222-y","volume":"15","author":"G Norman","year":"2010","unstructured":"Norman, G. Likert scales, levels of measurement and the laws of statistics. Adv. Health Sci. Educ. 15, 625\u2013632. https:\/\/doi.org\/10.1007\/s10459-010-9222-y (2010).","journal-title":"Adv. Health Sci. Educ."},{"key":"62116_CR33","doi-asserted-by":"crossref","unstructured":"Bender, R. & Lange, S. Letter to the editor concerning: What\u2019s wrong with arguments against multiplicity adjustments. BMJ. 316,1236-1238 (1998).","DOI":"10.1136\/bmj.316.7139.1236"},{"key":"62116_CR34","unstructured":"Cohen, J. Statistical power analysis for the behavioral sciences 2edn (L. Erlbaum Associates, 1988)."},{"key":"62116_CR35","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1136\/bmj.320.7247.1446","volume":"320","author":"N Steel","year":"2000","unstructured":"Steel, N. Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. Bmj 320, 1446\u20131447. https:\/\/doi.org\/10.1136\/bmj.320.7247.1446 (2000).","journal-title":"Bmj"},{"key":"62116_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/bmj.324.7332.278","volume":"324","author":"B Mintzes","year":"2002","unstructured":"Mintzes, B. et al. Influence of direct to consumer pharmaceutical advertising and patients\u2019 requests on prescribing decisions: two site cross sectional survey. Bmj 324, 278\u2013279 (2002).","journal-title":"Bmj"},{"key":"62116_CR37","doi-asserted-by":"publisher","first-page":"e1000352","DOI":"10.1371\/journal.pmed.1000352","volume":"7","author":"GK Spurling","year":"2010","unstructured":"Spurling, G. K. et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians\u2019 prescribing: a systematic review. PLoS Med. 7, e1000352 (2010).","journal-title":"PLoS Med."},{"key":"62116_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jama.283.3.373","volume":"283","author":"A Wazana","year":"2000","unstructured":"Wazana, A. Physicians and the pharmaceutical industry: is a gift ever just a gift? Jama 283, 373\u2013380 (2000).","journal-title":"Jama"},{"key":"62116_CR39","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1111\/obr.12934","volume":"20","author":"L Alonso-Pedrero","year":"2019","unstructured":"Alonso-Pedrero, L., Bes-Rastrollo, M. & Marti, A. Effects of antidepressant and antipsychotic use on weight gain: A systematic review. Obes. Rev. 20, 1680\u20131690. https:\/\/doi.org\/10.1111\/obr.12934 (2019).","journal-title":"Obes. Rev."},{"key":"62116_CR40","doi-asserted-by":"publisher","first-page":"204512532097032","DOI":"10.1177\/2045125320970325","volume":"10","author":"GA Fava","year":"2020","unstructured":"Fava, G. A. May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance. Therapeutic Adv. Psychopharmacol. 10, 2045125320970325. https:\/\/doi.org\/10.1177\/2045125320970325 (2020).","journal-title":"Therapeutic Adv. Psychopharmacol."},{"key":"62116_CR41","unstructured":"Ranjbar, S., Pai, N. B. & Deng, C. The Association of Antidepressant Medication and Body Weight Gain. Online J. Health Allied Scs. 12, 1-9 (2013)."},{"key":"62116_CR42","unstructured":"Bruhn, C. in DAZ.online (2019)."},{"key":"62116_CR43","unstructured":"Wolf, C. in Apotheken Umschau (2022)."},{"key":"62116_CR44","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.sapharm.2017.07.011","volume":"14","author":"M Green Lauridsen","year":"2018","unstructured":"Green Lauridsen, M. & K\u00e4lvemark Sporrong, S. How does media coverage effect the consumption of antidepressants? A study of the media coverage of antidepressants in Danish online newspapers 2010\u20132011. Res. Social Administrative Pharm. 14, 638\u2013644. https:\/\/doi.org\/10.1016\/j.sapharm.2017.07.011 (2018).","journal-title":"Res. Social Administrative Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62116-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:16:27Z","timestamp":1784132187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62116-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["62116"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-62116-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Friedrich-Alexander-University Erlangen-Nuremberg approved the study in January 2024 (file number: 23-491-B). The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave informed consent.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22283"}}